

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | nuclear pore complex assembly (GO:0051292) | 6.00298094 |
| 2 | nuclear pore organization (GO:0006999) | 5.16855890 |
| 3 | interkinetic nuclear migration (GO:0022027) | 4.94206135 |
| 4 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 4.63196743 |
| 5 | pre-miRNA processing (GO:0031054) | 4.57337677 |
| 6 | response to pheromone (GO:0019236) | 4.50094593 |
| 7 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 4.48063572 |
| 8 | pore complex assembly (GO:0046931) | 4.26204116 |
| 9 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 4.22571780 |
| 10 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 4.22571780 |
| 11 | mitotic sister chromatid cohesion (GO:0007064) | 4.21911324 |
| 12 | presynaptic membrane assembly (GO:0097105) | 4.19193260 |
| 13 | import into cell (GO:0098657) | 4.02451846 |
| 14 | dosage compensation (GO:0007549) | 3.95953433 |
| 15 | drinking behavior (GO:0042756) | 3.89234392 |
| 16 | definitive hemopoiesis (GO:0060216) | 3.87101636 |
| 17 | establishment of protein localization to Golgi (GO:0072600) | 3.86942973 |
| 18 | positive regulation of mitochondrial fission (GO:0090141) | 3.85447097 |
| 19 | lipid translocation (GO:0034204) | 3.83901730 |
| 20 | phospholipid translocation (GO:0045332) | 3.83901730 |
| 21 | tyrosine phosphorylation of STAT protein (GO:0007260) | 3.81473795 |
| 22 | histone H3-K9 methylation (GO:0051567) | 3.69769846 |
| 23 | pyrimidine dimer repair (GO:0006290) | 3.68712527 |
| 24 | positive regulation of developmental pigmentation (GO:0048087) | 3.67859123 |
| 25 | regulation of transforming growth factor beta2 production (GO:0032909) | 3.57810560 |
| 26 | G-protein coupled receptor internalization (GO:0002031) | 3.57605247 |
| 27 | COPII vesicle coating (GO:0048208) | 3.54506039 |
| 28 | monoubiquitinated protein deubiquitination (GO:0035520) | 3.54267384 |
| 29 | limb bud formation (GO:0060174) | 3.52905460 |
| 30 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 3.52566770 |
| 31 | cellular response to ethanol (GO:0071361) | 3.52562730 |
| 32 | microtubule anchoring (GO:0034453) | 3.52471064 |
| 33 | nucleotide transmembrane transport (GO:1901679) | 3.48149098 |
| 34 | regulation of pigment cell differentiation (GO:0050932) | 3.46623912 |
| 35 | peptidyl-lysine dimethylation (GO:0018027) | 3.46505679 |
| 36 | sister chromatid cohesion (GO:0007062) | 3.45248155 |
| 37 | regulation of timing of cell differentiation (GO:0048505) | 3.43996634 |
| 38 | histone mRNA catabolic process (GO:0071044) | 3.41882128 |
| 39 | presynaptic membrane organization (GO:0097090) | 3.41272177 |
| 40 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.40366993 |
| 41 | head development (GO:0060322) | 3.39227369 |
| 42 | protein targeting to Golgi (GO:0000042) | 3.36035653 |
| 43 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.35909276 |
| 44 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 3.35436894 |
| 45 | glucosamine-containing compound catabolic process (GO:1901072) | 3.30675154 |
| 46 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787) | 3.28122919 |
| 47 | cytoplasmic mRNA processing body assembly (GO:0033962) | 3.24377604 |
| 48 | polyketide metabolic process (GO:0030638) | 3.21411061 |
| 49 | doxorubicin metabolic process (GO:0044598) | 3.21411061 |
| 50 | daunorubicin metabolic process (GO:0044597) | 3.21411061 |
| 51 | postsynaptic membrane organization (GO:0001941) | 3.21253250 |
| 52 | centriole replication (GO:0007099) | 3.20607817 |
| 53 | centriole assembly (GO:0098534) | 3.19157072 |
| 54 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 3.17386263 |
| 55 | regulation of histone H3-K27 methylation (GO:0061085) | 3.15196913 |
| 56 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 3.14810060 |
| 57 | regulation of mitochondrial fission (GO:0090140) | 3.13381765 |
| 58 | regulation of RNA export from nucleus (GO:0046831) | 3.09240319 |
| 59 | neural tube formation (GO:0001841) | 3.08163532 |
| 60 | cranial nerve morphogenesis (GO:0021602) | 3.04029085 |
| 61 | intra-Golgi vesicle-mediated transport (GO:0006891) | 3.02815606 |
| 62 | developmental pigmentation (GO:0048066) | 3.01259329 |
| 63 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 2.97626212 |
| 64 | negative regulation of complement activation (GO:0045916) | 2.96747438 |
| 65 | microtubule nucleation (GO:0007020) | 2.94951222 |
| 66 | negative regulation of digestive system process (GO:0060457) | 2.94349054 |
| 67 | mesenchymal cell differentiation (GO:0048762) | 2.93783412 |
| 68 | negative regulation of osteoblast proliferation (GO:0033689) | 2.92697797 |
| 69 | early endosome to late endosome transport (GO:0045022) | 2.92170808 |
| 70 | kidney morphogenesis (GO:0060993) | 2.91815789 |
| 71 | righting reflex (GO:0060013) | 2.91794136 |
| 72 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.90147577 |
| 73 | histone H3-K4 trimethylation (GO:0080182) | 2.89918896 |
| 74 | negative regulation of protein activation cascade (GO:2000258) | 2.89734249 |
| 75 | histone H3-K9 modification (GO:0061647) | 2.89300390 |
| 76 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 2.88702400 |
| 77 | polyol transport (GO:0015791) | 2.88443720 |
| 78 | cellular response to epinephrine stimulus (GO:0071872) | 2.87780533 |
| 79 | cornea development in camera-type eye (GO:0061303) | 2.87541627 |
| 80 | cyclic nucleotide catabolic process (GO:0009214) | 2.87394722 |
| 81 | nucleus localization (GO:0051647) | 2.86972133 |
| 82 | maintenance of protein location in nucleus (GO:0051457) | 2.85172675 |
| 83 | retina layer formation (GO:0010842) | 2.84670058 |
| 84 | response to follicle-stimulating hormone (GO:0032354) | 2.84214547 |
| 85 | histone lysine methylation (GO:0034968) | 2.84190023 |
| 86 | protein heterotetramerization (GO:0051290) | 2.82687148 |
| 87 | hypotonic response (GO:0006971) | 2.81760629 |
| 88 | DNA integration (GO:0015074) | 2.80699934 |
| 89 | bone remodeling (GO:0046849) | 2.80511135 |
| 90 | histone lysine demethylation (GO:0070076) | 2.79760638 |
| 91 | cAMP catabolic process (GO:0006198) | 2.79438104 |
| 92 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.78832883 |
| 93 | regulation of development, heterochronic (GO:0040034) | 2.77823344 |
| 94 | histone demethylation (GO:0016577) | 2.76129178 |
| 95 | startle response (GO:0001964) | 2.75958277 |
| 96 | positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517) | 2.75945699 |
| 97 | superoxide anion generation (GO:0042554) | 2.72273120 |
| 98 | positive regulation of protein sumoylation (GO:0033235) | 2.70981160 |
| 99 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.69905610 |
| 100 | mitochondrial fission (GO:0000266) | 2.69313655 |
| 101 | response to epinephrine (GO:0071871) | 2.68988738 |
| 102 | lateral sprouting from an epithelium (GO:0060601) | 2.68445064 |
| 103 | regulation of oxidative stress-induced neuron death (GO:1903203) | 2.66905925 |
| 104 | DNA damage induced protein phosphorylation (GO:0006975) | 2.66825464 |
| 105 | poly(A)+ mRNA export from nucleus (GO:0016973) | 2.65557136 |
| 106 | keratinocyte development (GO:0003334) | 2.64900635 |
| 107 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.64184486 |
| 108 | centrosome duplication (GO:0051298) | 2.64182064 |
| 109 | regulation of centriole replication (GO:0046599) | 2.63994321 |
| 110 | histone H3-K36 demethylation (GO:0070544) | 2.63992380 |
| 111 | snRNA transcription (GO:0009301) | 2.62567053 |
| 112 | L-amino acid import (GO:0043092) | 2.62360849 |
| 113 | extracellular regulation of signal transduction (GO:1900115) | 2.61987980 |
| 114 | extracellular negative regulation of signal transduction (GO:1900116) | 2.61987980 |
| 115 | negative regulation of cardiac muscle hypertrophy (GO:0010614) | 2.61754196 |
| 116 | necrotic cell death (GO:0070265) | 2.61499032 |
| 117 | cell differentiation involved in kidney development (GO:0061005) | 2.59620972 |
| 118 | gastrulation with mouth forming second (GO:0001702) | 2.55823374 |
| 119 | hemoglobin metabolic process (GO:0020027) | 2.55544446 |
| 120 | glycoprotein catabolic process (GO:0006516) | 2.55536137 |
| 121 | non-recombinational repair (GO:0000726) | 2.55202425 |
| 122 | double-strand break repair via nonhomologous end joining (GO:0006303) | 2.55202425 |
| 123 | regulation of membrane lipid distribution (GO:0097035) | 2.55016218 |
| 124 | regulation of integrin activation (GO:0033623) | 2.54757857 |
| 125 | glucocorticoid receptor signaling pathway (GO:0042921) | 2.54333210 |
| 126 | spinal cord motor neuron differentiation (GO:0021522) | 2.53342803 |
| 127 | positive regulation by host of viral transcription (GO:0043923) | 2.52792945 |
| 128 | protein K11-linked deubiquitination (GO:0035871) | 2.52184301 |
| 129 | positive regulation of glycolytic process (GO:0045821) | 2.52028432 |
| 130 | regulation of non-canonical Wnt signaling pathway (GO:2000050) | 2.51327288 |
| 131 | embryonic camera-type eye morphogenesis (GO:0048596) | 2.51100999 |
| 132 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.51099345 |
| 133 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.51076073 |
| 134 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 2.50674370 |
| 135 | omega-hydroxylase P450 pathway (GO:0097267) | 2.50256102 |
| 136 | phosphatidylinositol phosphorylation (GO:0046854) | 2.50036022 |
| 137 | protein localization to cilium (GO:0061512) | 2.49155568 |
| 138 | organ growth (GO:0035265) | 2.48256286 |
| 139 | viral entry into host cell (GO:0046718) | 2.47985148 |
| 140 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.47681795 |
| 141 | mechanoreceptor differentiation (GO:0042490) | 2.47550155 |
| 142 | establishment of spindle orientation (GO:0051294) | 2.46395523 |
| 143 | protein K48-linked deubiquitination (GO:0071108) | 2.45973327 |
| 144 | cartilage morphogenesis (GO:0060536) | 2.45806983 |
| 145 | lymphoid progenitor cell differentiation (GO:0002320) | 2.45525913 |
| 146 | androgen receptor signaling pathway (GO:0030521) | 2.44048398 |
| 147 | response to lipoprotein particle (GO:0055094) | 2.43644729 |
| 148 | serotonin receptor signaling pathway (GO:0007210) | 2.43595621 |
| 149 | DNA geometric change (GO:0032392) | 2.43094185 |
| 150 | cranial nerve structural organization (GO:0021604) | 2.43009603 |
| 151 | cell proliferation in forebrain (GO:0021846) | 2.42130931 |
| 152 | cell differentiation involved in metanephros development (GO:0072202) | 2.41750049 |
| 153 | cellular response to ATP (GO:0071318) | 2.41392210 |
| 154 | DNA duplex unwinding (GO:0032508) | 2.39689245 |
| 155 | peptidyl-lysine methylation (GO:0018022) | 2.39361245 |
| 156 | protein dealkylation (GO:0008214) | 2.39251706 |
| 157 | protein demethylation (GO:0006482) | 2.39251706 |
| 158 | mesenchymal-epithelial cell signaling (GO:0060638) | 2.39113505 |
| 159 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.38478534 |
| 160 | pharyngeal system development (GO:0060037) | 2.38457573 |
| 161 | positive regulation of meiosis (GO:0045836) | 2.38394391 |
| 162 | negative regulation of cell cycle G2/M phase transition (GO:1902750) | 2.37776971 |
| 163 | cranial nerve development (GO:0021545) | 2.37766457 |
| 164 | regulation of sister chromatid cohesion (GO:0007063) | 2.37248935 |
| 165 | stress granule assembly (GO:0034063) | 2.36894058 |
| 166 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.35888086 |
| 167 | reflex (GO:0060004) | 2.35324466 |
| 168 | positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141) | 2.34465453 |
| 169 | regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139) | 2.34465453 |
| 170 | activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171) | 2.33741644 |
| 171 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.33688399 |
| 172 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.33688399 |
| 173 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.33688399 |
| 174 | oligosaccharide catabolic process (GO:0009313) | 2.33607104 |
| 175 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.33177154 |
| 176 | ganglion development (GO:0061548) | 2.32199513 |
| 177 | appendage development (GO:0048736) | 2.31084223 |
| 178 | limb development (GO:0060173) | 2.31084223 |
| 179 | establishment of protein localization to vacuole (GO:0072666) | 2.31026037 |
| 180 | protein targeting to vacuole (GO:0006623) | 2.31026037 |
| 181 | protein targeting to lysosome (GO:0006622) | 2.31026037 |
| 182 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.30240839 |
| 183 | negative regulation of myoblast differentiation (GO:0045662) | 2.27035403 |
| 184 | epithelial cilium movement (GO:0003351) | 2.26312138 |
| 185 | calcium ion import (GO:0070509) | 2.26223900 |
| 186 | olfactory bulb development (GO:0021772) | 2.26033958 |
| 187 | negative regulation of G-protein coupled receptor protein signaling pathway (GO:0045744) | 2.25206880 |
| 188 | positive regulation of protein kinase C signaling (GO:0090037) | 2.25154788 |
| 189 | prostate gland growth (GO:0060736) | 2.24398164 |
| 190 | eye photoreceptor cell development (GO:0042462) | 2.23943791 |
| 191 | neuron cell-cell adhesion (GO:0007158) | 2.22912052 |
| 192 | embryonic forelimb morphogenesis (GO:0035115) | 2.22368883 |
| 193 | negative regulation of muscle hypertrophy (GO:0014741) | 2.22168197 |
| 194 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.21689911 |
| 195 | photoreceptor cell maintenance (GO:0045494) | 2.21462327 |
| 196 | dentate gyrus development (GO:0021542) | 2.21442438 |
| 197 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 2.21411804 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GATA1_22025678_ChIP-Seq_K562_Human | 4.91302083 |
| 2 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 4.18381534 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.94269523 |
| 4 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.56573392 |
| 5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.40850263 |
| 6 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 3.19701307 |
| 7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.17133121 |
| 8 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.02891372 |
| 9 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.67326881 |
| 10 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.61114079 |
| 11 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.49383055 |
| 12 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 2.36495759 |
| 13 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.26177420 |
| 14 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.26032450 |
| 15 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.25082303 |
| 16 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.13918030 |
| 17 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.10152125 |
| 18 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.03902854 |
| 19 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 2.02522291 |
| 20 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 2.02304171 |
| 21 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.98615190 |
| 22 | P300_19829295_ChIP-Seq_ESCs_Human | 1.96565554 |
| 23 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.95645152 |
| 24 | * PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.94794947 |
| 25 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.92790645 |
| 26 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.91991649 |
| 27 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.90800709 |
| 28 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.90781297 |
| 29 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.90049919 |
| 30 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.89423598 |
| 31 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.89413933 |
| 32 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.89264988 |
| 33 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.89264138 |
| 34 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.85930390 |
| 35 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.82369678 |
| 36 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.82162911 |
| 37 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.81618692 |
| 38 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.81394293 |
| 39 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.80481997 |
| 40 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 1.79920807 |
| 41 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.79174342 |
| 42 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.78754653 |
| 43 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.78097333 |
| 44 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.78092345 |
| 45 | VDR_22108803_ChIP-Seq_LS180_Human | 1.76617872 |
| 46 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.76114865 |
| 47 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.74116228 |
| 48 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.73058311 |
| 49 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.72723973 |
| 50 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.72619039 |
| 51 | FUS_26573619_Chip-Seq_HEK293_Human | 1.69112297 |
| 52 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.68067364 |
| 53 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.64948259 |
| 54 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.63526569 |
| 55 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.63360466 |
| 56 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.62967238 |
| 57 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.61318212 |
| 58 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.60620481 |
| 59 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.60620481 |
| 60 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.58465533 |
| 61 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.57974292 |
| 62 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.57429308 |
| 63 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.56354114 |
| 64 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.56058445 |
| 65 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.55637348 |
| 66 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.55463245 |
| 67 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.54229960 |
| 68 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.54103846 |
| 69 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.52945372 |
| 70 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.52925276 |
| 71 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.52356694 |
| 72 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.50578883 |
| 73 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.50038222 |
| 74 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.49664746 |
| 75 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.49247677 |
| 76 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.48298932 |
| 77 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.48150324 |
| 78 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.47218946 |
| 79 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.47114397 |
| 80 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.47035552 |
| 81 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.46970223 |
| 82 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.45986080 |
| 83 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.42857325 |
| 84 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.41630240 |
| 85 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.41437740 |
| 86 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.40810030 |
| 87 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.40144363 |
| 88 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.39710168 |
| 89 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.38843897 |
| 90 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.38361295 |
| 91 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.38361295 |
| 92 | EWS_26573619_Chip-Seq_HEK293_Human | 1.38178715 |
| 93 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.37801070 |
| 94 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.37513044 |
| 95 | * PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.37122632 |
| 96 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.35500628 |
| 97 | STAT3_23295773_ChIP-Seq_U87_Human | 1.35431819 |
| 98 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.33867580 |
| 99 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.32935224 |
| 100 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.31819589 |
| 101 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.31585265 |
| 102 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.31367834 |
| 103 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.30999674 |
| 104 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.30182739 |
| 105 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.30128283 |
| 106 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.30028517 |
| 107 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.29977866 |
| 108 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.29396972 |
| 109 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.29314162 |
| 110 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.29192744 |
| 111 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.29160273 |
| 112 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.28557691 |
| 113 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.28089946 |
| 114 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.27909402 |
| 115 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.27745489 |
| 116 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.26252220 |
| 117 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.26252220 |
| 118 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.26061215 |
| 119 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.25574384 |
| 120 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.24227258 |
| 121 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.23865440 |
| 122 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.23862174 |
| 123 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.23452001 |
| 124 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.23328336 |
| 125 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.22531224 |
| 126 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.21649782 |
| 127 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.21173593 |
| 128 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.19595900 |
| 129 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.18786075 |
| 130 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.18771997 |
| 131 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.18121603 |
| 132 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.17804853 |
| 133 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.17485324 |
| 134 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.17119102 |
| 135 | KDM2B_26808549_Chip-Seq_REH_Human | 1.12796083 |
| 136 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.12530164 |
| 137 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.12530164 |
| 138 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.12514379 |
| 139 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.12280081 |
| 140 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.11761601 |
| 141 | TP53_16413492_ChIP-PET_HCT116_Human | 1.11549302 |
| 142 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.11350974 |
| 143 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.11078012 |
| 144 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 1.09667929 |
| 145 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.09373973 |
| 146 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.07230486 |
| 147 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.06752637 |
| 148 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.04011965 |
| 149 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.03119676 |
| 150 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.02199993 |
| 151 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.02108048 |
| 152 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.02100961 |
| 153 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.98933444 |
| 154 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96943557 |
| 155 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.95339102 |
| 156 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.93531512 |
| 157 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.91603073 |
| 158 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.91603073 |
| 159 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.89296732 |
| 160 | CJUN_26792858_Chip-Seq_BT549_Human | 0.88094024 |
| 161 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.87443524 |
| 162 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.85676982 |
| 163 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.85344604 |
| 164 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.85025354 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008057_abnormal_DNA_replication | 4.23476184 |
| 2 | MP0006292_abnormal_olfactory_placode | 3.81498218 |
| 3 | MP0002009_preneoplasia | 3.73351898 |
| 4 | MP0001188_hyperpigmentation | 3.69420865 |
| 5 | MP0003136_yellow_coat_color | 3.62935323 |
| 6 | MP0002102_abnormal_ear_morphology | 3.41271846 |
| 7 | MP0005409_darkened_coat_color | 3.33901812 |
| 8 | MP0000566_synostosis | 3.28537981 |
| 9 | MP0002166_altered_tumor_susceptibility | 2.56748162 |
| 10 | MP0000015_abnormal_ear_pigmentation | 2.55326811 |
| 11 | MP0005646_abnormal_pituitary_gland | 2.45682512 |
| 12 | MP0004381_abnormal_hair_follicle | 2.26242353 |
| 13 | MP0000013_abnormal_adipose_tissue | 2.24328839 |
| 14 | MP0005645_abnormal_hypothalamus_physiol | 2.22438658 |
| 15 | MP0002277_abnormal_respiratory_mucosa | 2.20035470 |
| 16 | MP0001486_abnormal_startle_reflex | 2.14626554 |
| 17 | MP0005076_abnormal_cell_differentiation | 2.13464967 |
| 18 | MP0002249_abnormal_larynx_morphology | 2.11380050 |
| 19 | MP0001915_intracranial_hemorrhage | 2.10581601 |
| 20 | MP0001529_abnormal_vocalization | 2.07600379 |
| 21 | MP0005174_abnormal_tail_pigmentation | 2.03721411 |
| 22 | MP0002876_abnormal_thyroid_physiology | 2.02360268 |
| 23 | MP0005171_absent_coat_pigmentation | 1.98629240 |
| 24 | MP0002638_abnormal_pupillary_reflex | 1.98600427 |
| 25 | MP0000049_abnormal_middle_ear | 1.97469744 |
| 26 | MP0001986_abnormal_taste_sensitivity | 1.95490297 |
| 27 | MP0003787_abnormal_imprinting | 1.93737819 |
| 28 | MP0000569_abnormal_digit_pigmentation | 1.93107558 |
| 29 | MP0010352_gastrointestinal_tract_polyps | 1.88585491 |
| 30 | MP0003880_abnormal_central_pattern | 1.87995643 |
| 31 | MP0002877_abnormal_melanocyte_morpholog | 1.87611231 |
| 32 | MP0008438_abnormal_cutaneous_collagen | 1.84972320 |
| 33 | MP0002006_tumorigenesis | 1.84532011 |
| 34 | MP0003191_abnormal_cellular_cholesterol | 1.82599297 |
| 35 | MP0004742_abnormal_vestibular_system | 1.82198987 |
| 36 | MP0002938_white_spotting | 1.80637985 |
| 37 | MP0003091_abnormal_cell_migration | 1.79893357 |
| 38 | MP0001661_extended_life_span | 1.75566025 |
| 39 | MP0010094_abnormal_chromosome_stability | 1.72986528 |
| 40 | MP0000678_abnormal_parathyroid_gland | 1.68522202 |
| 41 | MP0005075_abnormal_melanosome_morpholog | 1.66832578 |
| 42 | MP0004808_abnormal_hematopoietic_stem | 1.66623583 |
| 43 | MP0005379_endocrine/exocrine_gland_phen | 1.65514437 |
| 44 | MP0002177_abnormal_outer_ear | 1.62567390 |
| 45 | MP0003938_abnormal_ear_development | 1.60582548 |
| 46 | MP0000026_abnormal_inner_ear | 1.60405264 |
| 47 | MP0000631_abnormal_neuroendocrine_gland | 1.58177003 |
| 48 | MP0003221_abnormal_cardiomyocyte_apopto | 1.57613760 |
| 49 | MP0009250_abnormal_appendicular_skeleto | 1.55801841 |
| 50 | MP0002396_abnormal_hematopoietic_system | 1.54947140 |
| 51 | MP0008995_early_reproductive_senescence | 1.50241678 |
| 52 | MP0001963_abnormal_hearing_physiology | 1.49219133 |
| 53 | MP0010368_abnormal_lymphatic_system | 1.46877800 |
| 54 | MP0005187_abnormal_penis_morphology | 1.44792152 |
| 55 | MP0005257_abnormal_intraocular_pressure | 1.44412430 |
| 56 | MP0002132_abnormal_respiratory_system | 1.43274146 |
| 57 | MP0003878_abnormal_ear_physiology | 1.41694467 |
| 58 | MP0005377_hearing/vestibular/ear_phenot | 1.41694467 |
| 59 | MP0004084_abnormal_cardiac_muscle | 1.39636509 |
| 60 | MP0000681_abnormal_thyroid_gland | 1.39505334 |
| 61 | MP0003943_abnormal_hepatobiliary_system | 1.35700707 |
| 62 | MP0005397_hematopoietic_system_phenotyp | 1.35478417 |
| 63 | MP0001545_abnormal_hematopoietic_system | 1.35478417 |
| 64 | MP0001984_abnormal_olfaction | 1.34306728 |
| 65 | MP0000372_irregular_coat_pigmentation | 1.34274046 |
| 66 | MP0001879_abnormal_lymphatic_vessel | 1.33965993 |
| 67 | MP0002095_abnormal_skin_pigmentation | 1.33633983 |
| 68 | MP0006054_spinal_hemorrhage | 1.32514534 |
| 69 | MP0003656_abnormal_erythrocyte_physiolo | 1.31897057 |
| 70 | MP0001485_abnormal_pinna_reflex | 1.30140085 |
| 71 | MP0003984_embryonic_growth_retardation | 1.29919773 |
| 72 | MP0004130_abnormal_muscle_cell | 1.28218204 |
| 73 | MP0000465_gastrointestinal_hemorrhage | 1.28050911 |
| 74 | MP0009745_abnormal_behavioral_response | 1.27513968 |
| 75 | MP0005621_abnormal_cell_physiology | 1.27026436 |
| 76 | MP0002088_abnormal_embryonic_growth/wei | 1.25818282 |
| 77 | MP0002557_abnormal_social/conspecific_i | 1.24204869 |
| 78 | MP0006072_abnormal_retinal_apoptosis | 1.21296649 |
| 79 | MP0008007_abnormal_cellular_replicative | 1.20406183 |
| 80 | MP0009697_abnormal_copulation | 1.19590218 |
| 81 | MP0001440_abnormal_grooming_behavior | 1.19421898 |
| 82 | MP0003121_genomic_imprinting | 1.18460361 |
| 83 | MP0005423_abnormal_somatic_nervous | 1.18401793 |
| 84 | MP0005248_abnormal_Harderian_gland | 1.18388470 |
| 85 | MP0005551_abnormal_eye_electrophysiolog | 1.17590359 |
| 86 | MP0005670_abnormal_white_adipose | 1.17567432 |
| 87 | MP0004233_abnormal_muscle_weight | 1.16071658 |
| 88 | MP0003077_abnormal_cell_cycle | 1.14846362 |
| 89 | MP0002233_abnormal_nose_morphology | 1.14237402 |
| 90 | MP0010386_abnormal_urinary_bladder | 1.13862848 |
| 91 | MP0005253_abnormal_eye_physiology | 1.12282494 |
| 92 | MP0004885_abnormal_endolymph | 1.12244843 |
| 93 | MP0002138_abnormal_hepatobiliary_system | 1.11802639 |
| 94 | MP0003937_abnormal_limbs/digits/tail_de | 1.09484252 |
| 95 | MP0005384_cellular_phenotype | 1.06128022 |
| 96 | MP0008260_abnormal_autophagy | 1.04726201 |
| 97 | MP0001672_abnormal_embryogenesis/_devel | 1.04309081 |
| 98 | MP0005380_embryogenesis_phenotype | 1.04309081 |
| 99 | MP0005167_abnormal_blood-brain_barrier | 1.03206319 |
| 100 | MP0004134_abnormal_chest_morphology | 1.03045658 |
| 101 | MP0003566_abnormal_cell_adhesion | 1.03006938 |
| 102 | MP0006276_abnormal_autonomic_nervous | 1.02687699 |
| 103 | MP0004036_abnormal_muscle_relaxation | 1.02677723 |
| 104 | MP0002086_abnormal_extraembryonic_tissu | 1.02563803 |
| 105 | MP0005499_abnormal_olfactory_system | 1.02025578 |
| 106 | MP0005394_taste/olfaction_phenotype | 1.02025578 |
| 107 | MP0005647_abnormal_sex_gland | 1.01728822 |
| 108 | MP0003763_abnormal_thymus_physiology | 0.97652607 |
| 109 | MP0002572_abnormal_emotion/affect_behav | 0.97618259 |
| 110 | MP0002067_abnormal_sensory_capabilities | 0.97496455 |
| 111 | MP0005275_abnormal_skin_tensile | 0.96406801 |
| 112 | MP0000778_abnormal_nervous_system | 0.96224487 |
| 113 | MP0004272_abnormal_basement_membrane | 0.94650944 |
| 114 | MP0005595_abnormal_vascular_smooth | 0.94118203 |
| 115 | MP0004197_abnormal_fetal_growth/weight/ | 0.93338303 |
| 116 | MP0008789_abnormal_olfactory_epithelium | 0.92752421 |
| 117 | MP0001501_abnormal_sleep_pattern | 0.91688111 |
| 118 | MP0001730_embryonic_growth_arrest | 0.91588647 |
| 119 | MP0003724_increased_susceptibility_to | 0.91220068 |
| 120 | MP0002128_abnormal_blood_circulation | 0.90076391 |
| 121 | MP0009278_abnormal_bone_marrow | 0.89843346 |
| 122 | MP0005464_abnormal_platelet_physiology | 0.89251638 |
| 123 | MP0001502_abnormal_circadian_rhythm | 0.88893234 |
| 124 | MP0002163_abnormal_gland_morphology | 0.88788846 |
| 125 | MP0008961_abnormal_basal_metabolism | 0.87739182 |
| 126 | MP0003868_abnormal_feces_composition | 0.87612109 |
| 127 | MP0000733_abnormal_muscle_development | 0.86535306 |
| 128 | * MP0002084_abnormal_developmental_patter | 0.86438307 |
| 129 | MP0009780_abnormal_chondrocyte_physiolo | 0.86093612 |
| 130 | MP0009115_abnormal_fat_cell | 0.86085828 |
| 131 | MP0002928_abnormal_bile_duct | 0.85364427 |
| 132 | MP0002272_abnormal_nervous_system | 0.85278921 |
| 133 | MP0003935_abnormal_craniofacial_develop | 0.85259124 |
| 134 | MP0000003_abnormal_adipose_tissue | 0.84946569 |
| 135 | MP0003755_abnormal_palate_morphology | 0.84346284 |
| 136 | MP0001177_atelectasis | 0.84088583 |
| 137 | MP0000383_abnormal_hair_follicle | 0.83421949 |
| 138 | MP0001299_abnormal_eye_distance/ | 0.83137503 |
| 139 | MP0001186_pigmentation_phenotype | 0.82620257 |
| 140 | MP0003879_abnormal_hair_cell | 0.82303641 |
| 141 | MP0003300_gastrointestinal_ulcer | 0.82072785 |
| 142 | MP0003950_abnormal_plasma_membrane | 0.80745907 |
| 143 | MP0000432_abnormal_head_morphology | 0.79992085 |
| 144 | MP0005310_abnormal_salivary_gland | 0.79615541 |
| 145 | MP0003646_muscle_fatigue | 0.77383070 |
| 146 | MP0002735_abnormal_chemical_nociception | 0.76785695 |
| 147 | MP0009046_muscle_twitch | 0.76675844 |
| 148 | MP0002116_abnormal_craniofacial_bone | 0.76494824 |
| 149 | MP0002693_abnormal_pancreas_physiology | 0.75938023 |
| 150 | MP0000350_abnormal_cell_proliferation | 0.75238752 |
| 151 | MP0003567_abnormal_fetal_cardiomyocyte | 0.73879468 |
| 152 | MP0002751_abnormal_autonomic_nervous | 0.73180977 |
| 153 | MP0002998_abnormal_bone_remodeling | 0.72476936 |
| 154 | MP0002752_abnormal_somatic_nervous | 0.72258174 |
| 155 | MP0004043_abnormal_pH_regulation | 0.71404085 |
| 156 | MP0004142_abnormal_muscle_tone | 0.70982301 |
| 157 | MP0001790_abnormal_immune_system | 0.70708874 |
| 158 | MP0005387_immune_system_phenotype | 0.70708874 |
| 159 | MP0000163_abnormal_cartilage_morphology | 0.70494317 |
| 160 | MP0000613_abnormal_salivary_gland | 0.70283502 |
| 161 | MP0002933_joint_inflammation | 0.70192157 |
| 162 | MP0000428_abnormal_craniofacial_morphol | 0.68854062 |
| 163 | MP0000371_diluted_coat_color | 0.68202668 |
| 164 | MP0003385_abnormal_body_wall | 0.67957594 |
| 165 | MP0002075_abnormal_coat/hair_pigmentati | 0.67945097 |
| 166 | MP0002822_catalepsy | 0.67765974 |
| 167 | MP0002092_abnormal_eye_morphology | 0.67628660 |
| 168 | MP0001697_abnormal_embryo_size | 0.67314907 |
| 169 | MP0003890_abnormal_embryonic-extraembry | 0.66296998 |
| 170 | MP0005391_vision/eye_phenotype | 0.65712144 |
| 171 | MP0002332_abnormal_exercise_endurance | 0.64331707 |
| 172 | MP0002127_abnormal_cardiovascular_syste | 0.64277809 |
| 173 | * MP0002925_abnormal_cardiovascular_devel | 0.62031374 |
| 174 | MP0002139_abnormal_hepatobiliary_system | 0.62014240 |
| 175 | MP0002080_prenatal_lethality | 0.60724144 |
| 176 | MP0003699_abnormal_female_reproductive | 0.60189112 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Lip pit (HP:0100267) | 4.17223842 |
| 2 | Papillary thyroid carcinoma (HP:0002895) | 3.96479567 |
| 3 | Osteomalacia (HP:0002749) | 3.73835048 |
| 4 | Volvulus (HP:0002580) | 3.67200180 |
| 5 | Abnormality of the renal collecting system (HP:0004742) | 3.45654701 |
| 6 | Absent/shortened dynein arms (HP:0200106) | 3.44826398 |
| 7 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.44826398 |
| 8 | Submucous cleft hard palate (HP:0000176) | 3.33728939 |
| 9 | Aplasia cutis congenita (HP:0001057) | 3.31272128 |
| 10 | White forelock (HP:0002211) | 3.29911727 |
| 11 | Nasolacrimal duct obstruction (HP:0000579) | 3.29815506 |
| 12 | Menstrual irregularities (HP:0000858) | 3.23799467 |
| 13 | Septo-optic dysplasia (HP:0100842) | 3.21896478 |
| 14 | Morphological abnormality of the middle ear (HP:0008609) | 3.16875360 |
| 15 | Patchy hypopigmentation of hair (HP:0011365) | 3.11959551 |
| 16 | Decreased central vision (HP:0007663) | 3.04555298 |
| 17 | Sandal gap (HP:0001852) | 2.94603026 |
| 18 | Chronic hepatic failure (HP:0100626) | 2.94292819 |
| 19 | Hand muscle atrophy (HP:0009130) | 2.90061480 |
| 20 | Abnormal ciliary motility (HP:0012262) | 2.82160151 |
| 21 | Abnormality of the lacrimal duct (HP:0011481) | 2.80836271 |
| 22 | Abnormality of incisor morphology (HP:0011063) | 2.79296028 |
| 23 | Cutis marmorata (HP:0000965) | 2.78305099 |
| 24 | Hip dysplasia (HP:0001385) | 2.76987135 |
| 25 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.74740362 |
| 26 | True hermaphroditism (HP:0010459) | 2.71838152 |
| 27 | Aplasia involving bones of the extremities (HP:0009825) | 2.70496206 |
| 28 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.70496206 |
| 29 | Aplasia of the phalanges of the hand (HP:0009802) | 2.70496206 |
| 30 | Truncal obesity (HP:0001956) | 2.66814033 |
| 31 | Prominent nose (HP:0000448) | 2.66565243 |
| 32 | Febrile seizures (HP:0002373) | 2.64879899 |
| 33 | Abnormality of the nasolacrimal system (HP:0000614) | 2.64361998 |
| 34 | Fair hair (HP:0002286) | 2.61916527 |
| 35 | Long foot (HP:0001833) | 2.61083468 |
| 36 | Acute myeloid leukemia (HP:0004808) | 2.58972303 |
| 37 | Entropion (HP:0000621) | 2.58634989 |
| 38 | Pancreatic cysts (HP:0001737) | 2.57953927 |
| 39 | Low anterior hairline (HP:0000294) | 2.56465018 |
| 40 | Thyroid carcinoma (HP:0002890) | 2.54830265 |
| 41 | Pancreatic fibrosis (HP:0100732) | 2.54211178 |
| 42 | Subacute progressive viral hepatitis (HP:0006572) | 2.51180236 |
| 43 | Chromsome breakage (HP:0040012) | 2.50899021 |
| 44 | Genetic anticipation (HP:0003743) | 2.50690598 |
| 45 | Short chin (HP:0000331) | 2.50350400 |
| 46 | Scanning speech (HP:0002168) | 2.45078980 |
| 47 | Absent speech (HP:0001344) | 2.42097550 |
| 48 | Abnormal biliary tract physiology (HP:0012439) | 2.41953277 |
| 49 | Bile duct proliferation (HP:0001408) | 2.41953277 |
| 50 | * Tubulointerstitial nephritis (HP:0001970) | 2.40699877 |
| 51 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.38079607 |
| 52 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.38079607 |
| 53 | Conjugated hyperbilirubinemia (HP:0002908) | 2.37793356 |
| 54 | Congenital sensorineural hearing impairment (HP:0008527) | 2.37123904 |
| 55 | Nephronophthisis (HP:0000090) | 2.33087978 |
| 56 | Cupped ear (HP:0000378) | 2.31759946 |
| 57 | Persistence of primary teeth (HP:0006335) | 2.30681572 |
| 58 | * Abnormality of the renal medulla (HP:0100957) | 2.29449835 |
| 59 | Mixed hearing impairment (HP:0000410) | 2.29255004 |
| 60 | Neuroendocrine neoplasm (HP:0100634) | 2.29112927 |
| 61 | Abnormality of the epiphyses of the phalanges of the hand (HP:0005920) | 2.28883748 |
| 62 | Large earlobe (HP:0009748) | 2.28768960 |
| 63 | Prolonged partial thromboplastin time (HP:0003645) | 2.27711244 |
| 64 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 2.27644664 |
| 65 | Widely spaced teeth (HP:0000687) | 2.27445917 |
| 66 | Fibular hypoplasia (HP:0003038) | 2.26839716 |
| 67 | Fibular aplasia (HP:0002990) | 2.25478972 |
| 68 | Exotropia (HP:0000577) | 2.24017193 |
| 69 | Difficulty running (HP:0009046) | 2.23267976 |
| 70 | Long eyelashes (HP:0000527) | 2.22537093 |
| 71 | Abnormality of the nasal septum (HP:0000419) | 2.22458323 |
| 72 | Optic nerve hypoplasia (HP:0000609) | 2.21202260 |
| 73 | Renal dysplasia (HP:0000110) | 2.21190166 |
| 74 | Generalized hypopigmentation of hair (HP:0011358) | 2.21169690 |
| 75 | Abnormality of the fingertips (HP:0001211) | 2.20484585 |
| 76 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 2.20385915 |
| 77 | Upper limb amyotrophy (HP:0009129) | 2.18273608 |
| 78 | Distal upper limb amyotrophy (HP:0007149) | 2.18273608 |
| 79 | Thick eyebrow (HP:0000574) | 2.15384600 |
| 80 | Conical tooth (HP:0000698) | 2.14846171 |
| 81 | Heterotopia (HP:0002282) | 2.14091597 |
| 82 | Flat acetabular roof (HP:0003180) | 2.12712425 |
| 83 | Craniofacial hyperostosis (HP:0004493) | 2.11869355 |
| 84 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.10976573 |
| 85 | Hypoplasia of the fovea (HP:0007750) | 2.10976573 |
| 86 | Duplicated collecting system (HP:0000081) | 2.10578881 |
| 87 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.09377066 |
| 88 | Gonadotropin excess (HP:0000837) | 2.07472643 |
| 89 | Overgrowth (HP:0001548) | 2.06232401 |
| 90 | Facial diplegia (HP:0001349) | 2.04815491 |
| 91 | Abnormality of midbrain morphology (HP:0002418) | 2.04663463 |
| 92 | Molar tooth sign on MRI (HP:0002419) | 2.04663463 |
| 93 | Cystic liver disease (HP:0006706) | 2.03855990 |
| 94 | Abnormality of the epiphyses of the hand (HP:0005924) | 2.03116603 |
| 95 | Central scotoma (HP:0000603) | 2.01959106 |
| 96 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.00951710 |
| 97 | Drooling (HP:0002307) | 2.00892238 |
| 98 | Dysmetric saccades (HP:0000641) | 1.99907138 |
| 99 | Gingival bleeding (HP:0000225) | 1.99379223 |
| 100 | Chronic sinusitis (HP:0011109) | 1.98883851 |
| 101 | Increased mean platelet volume (HP:0011877) | 1.98143570 |
| 102 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.97881598 |
| 103 | Viral hepatitis (HP:0006562) | 1.97314218 |
| 104 | Short tibia (HP:0005736) | 1.96844463 |
| 105 | Abnormality of the fibula (HP:0002991) | 1.94136473 |
| 106 | Abnormality involving the epiphyses of the upper limbs (HP:0003839) | 1.93897222 |
| 107 | Broad-based gait (HP:0002136) | 1.93629381 |
| 108 | Narrow palate (HP:0000189) | 1.93140823 |
| 109 | Hypoalphalipoproteinemia (HP:0003233) | 1.91337993 |
| 110 | Hypophosphatemic rickets (HP:0004912) | 1.90782894 |
| 111 | Postaxial foot polydactyly (HP:0001830) | 1.90044257 |
| 112 | Septate vagina (HP:0001153) | 1.89919585 |
| 113 | Hypoglycemic seizures (HP:0002173) | 1.89547945 |
| 114 | Preaxial hand polydactyly (HP:0001177) | 1.88937730 |
| 115 | Median cleft lip (HP:0000161) | 1.88569309 |
| 116 | Male pseudohermaphroditism (HP:0000037) | 1.86310868 |
| 117 | Cranial hyperostosis (HP:0004437) | 1.86147807 |
| 118 | Hypoplastic pelvis (HP:0008839) | 1.85101556 |
| 119 | Alacrima (HP:0000522) | 1.84865805 |
| 120 | Joint hemorrhage (HP:0005261) | 1.84172934 |
| 121 | Abnormality of the parietal bone (HP:0002696) | 1.83775261 |
| 122 | Absent septum pellucidum (HP:0001331) | 1.83411770 |
| 123 | Increased density of long bones (HP:0006392) | 1.83255391 |
| 124 | Aplasia/Hypoplasia of the fibula (HP:0006492) | 1.83041931 |
| 125 | Partial agenesis of the corpus callosum (HP:0001338) | 1.82031268 |
| 126 | Excessive salivation (HP:0003781) | 1.81087518 |
| 127 | Hypoplastic iliac wings (HP:0002866) | 1.80479165 |
| 128 | Cortical dysplasia (HP:0002539) | 1.79601097 |
| 129 | Alveolar cell carcinoma (HP:0006519) | 1.79547064 |
| 130 | Asymmetry of the thorax (HP:0001555) | 1.79483272 |
| 131 | Progressive sensorineural hearing impairment (HP:0000408) | 1.78681501 |
| 132 | Long toe (HP:0010511) | 1.78062157 |
| 133 | Midline defect of the nose (HP:0004122) | 1.77984154 |
| 134 | Overfolded helix (HP:0000396) | 1.77579692 |
| 135 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.76680634 |
| 136 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.76469006 |
| 137 | Poikiloderma (HP:0001029) | 1.75980613 |
| 138 | Duplication of thumb phalanx (HP:0009942) | 1.75623773 |
| 139 | Acute lymphatic leukemia (HP:0006721) | 1.75076365 |
| 140 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.74983009 |
| 141 | Metabolic alkalosis (HP:0200114) | 1.74839789 |
| 142 | Complete atrioventricular canal defect (HP:0001674) | 1.74440124 |
| 143 | Obsessive-compulsive behavior (HP:0000722) | 1.73916727 |
| 144 | Smooth philtrum (HP:0000319) | 1.73891452 |
| 145 | Advanced eruption of teeth (HP:0006288) | 1.73478986 |
| 146 | Focal motor seizures (HP:0011153) | 1.72436280 |
| 147 | Agammaglobulinemia (HP:0004432) | 1.71822553 |
| 148 | Decreased lacrimation (HP:0000633) | 1.70525175 |
| 149 | Attenuation of retinal blood vessels (HP:0007843) | 1.70080642 |
| 150 | Abnormality of the incisor (HP:0000676) | 1.69600164 |
| 151 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.68894885 |
| 152 | Sparse lateral eyebrow (HP:0005338) | 1.68484570 |
| 153 | Accelerated skeletal maturation (HP:0005616) | 1.68444815 |
| 154 | Clubbing of toes (HP:0100760) | 1.67565439 |
| 155 | Progressive inability to walk (HP:0002505) | 1.67089034 |
| 156 | Symptomatic seizures (HP:0011145) | 1.66777099 |
| 157 | High anterior hairline (HP:0009890) | 1.66579985 |
| 158 | Colitis (HP:0002583) | 1.65197118 |
| 159 | Long clavicles (HP:0000890) | 1.65023079 |
| 160 | Blue irides (HP:0000635) | 1.65009715 |
| 161 | Abnormality of DNA repair (HP:0003254) | 1.64138415 |
| 162 | Deep philtrum (HP:0002002) | 1.63632389 |
| 163 | Open mouth (HP:0000194) | 1.63462277 |
| 164 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.63389621 |
| 165 | Deviation of the thumb (HP:0009603) | 1.63120608 |
| 166 | Abnormal platelet volume (HP:0011876) | 1.63090518 |
| 167 | Pheochromocytoma (HP:0002666) | 1.63011979 |
| 168 | Atelectasis (HP:0100750) | 1.62701618 |
| 169 | Pulmonary artery stenosis (HP:0004415) | 1.62542577 |
| 170 | Protruding tongue (HP:0010808) | 1.62362509 |
| 171 | Hypothermia (HP:0002045) | 1.61804597 |
| 172 | Tapered finger (HP:0001182) | 1.61307765 |
| 173 | Popliteal pterygium (HP:0009756) | 1.60969052 |
| 174 | Hematochezia (HP:0002573) | 1.60866454 |
| 175 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.60636679 |
| 176 | Skull defect (HP:0001362) | 1.60512733 |
| 177 | Bladder neoplasm (HP:0009725) | 1.60453798 |
| 178 | Bladder carcinoma (HP:0002862) | 1.60453798 |
| 179 | Renal tubular dysfunction (HP:0000124) | 1.60221596 |
| 180 | Decreased circulating renin level (HP:0003351) | 1.60115823 |
| 181 | Absent frontal sinuses (HP:0002688) | 1.60066795 |
| 182 | Postnatal growth retardation (HP:0008897) | 1.59223521 |
| 183 | Ectropion (HP:0000656) | 1.58937602 |
| 184 | Chronic diarrhea (HP:0002028) | 1.58362342 |
| 185 | Albinism (HP:0001022) | 1.58302251 |
| 186 | Relative macrocephaly (HP:0004482) | 1.55779284 |
| 187 | Abnormality of the astrocytes (HP:0100707) | 1.55669564 |
| 188 | Astrocytoma (HP:0009592) | 1.55669564 |
| 189 | Myelomeningocele (HP:0002475) | 1.55600384 |
| 190 | Pulmonic stenosis (HP:0001642) | 1.54222871 |
| 191 | Medial flaring of the eyebrow (HP:0010747) | 1.54167257 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 3.94506522 |
| 2 | INSRR | 3.67246857 |
| 3 | TNIK | 3.65938890 |
| 4 | BLK | 3.33947525 |
| 5 | MKNK2 | 3.27072626 |
| 6 | MAP3K4 | 3.20628272 |
| 7 | SCYL2 | 2.59492949 |
| 8 | MAP3K6 | 2.58307227 |
| 9 | TAOK3 | 2.44536509 |
| 10 | CDK12 | 2.37752052 |
| 11 | ZAK | 2.29514136 |
| 12 | IRAK4 | 2.04421595 |
| 13 | TRPM7 | 2.01571120 |
| 14 | STK16 | 1.93185242 |
| 15 | MKNK1 | 1.90471656 |
| 16 | ERBB3 | 1.89940093 |
| 17 | SIK3 | 1.89185820 |
| 18 | MAP3K14 | 1.83428186 |
| 19 | FLT3 | 1.82415073 |
| 20 | TXK | 1.81231466 |
| 21 | IRAK3 | 1.75825587 |
| 22 | SIK2 | 1.74436600 |
| 23 | NUAK1 | 1.74075631 |
| 24 | MAP4K2 | 1.71439982 |
| 25 | MAP3K13 | 1.70886489 |
| 26 | NEK9 | 1.69549321 |
| 27 | NTRK3 | 1.68722025 |
| 28 | BRD4 | 1.68552728 |
| 29 | MAPK11 | 1.64838993 |
| 30 | NEK6 | 1.64009571 |
| 31 | GRK1 | 1.53074729 |
| 32 | MET | 1.52801312 |
| 33 | EIF2AK2 | 1.50304888 |
| 34 | MAPK13 | 1.45479574 |
| 35 | PLK4 | 1.40632193 |
| 36 | YES1 | 1.37722912 |
| 37 | FER | 1.32488420 |
| 38 | ADRBK2 | 1.31264480 |
| 39 | PIK3CA | 1.30682029 |
| 40 | MAP3K7 | 1.27490211 |
| 41 | PKN1 | 1.27485048 |
| 42 | FRK | 1.27457509 |
| 43 | IRAK2 | 1.23345772 |
| 44 | EIF2AK3 | 1.21952057 |
| 45 | CDK3 | 1.19965341 |
| 46 | RIPK4 | 1.19889925 |
| 47 | SRPK1 | 1.19166189 |
| 48 | BMPR2 | 1.18910345 |
| 49 | ICK | 1.18613398 |
| 50 | MAP2K4 | 1.17810265 |
| 51 | CAMK1G | 1.17640152 |
| 52 | MST1R | 1.15865841 |
| 53 | NLK | 1.13539155 |
| 54 | CCNB1 | 1.12631986 |
| 55 | WNK3 | 1.09057072 |
| 56 | AKT3 | 1.07952903 |
| 57 | MAPK15 | 1.06754782 |
| 58 | PDGFRA | 1.06710050 |
| 59 | TEC | 1.04923266 |
| 60 | PINK1 | 1.03679517 |
| 61 | BRSK2 | 1.02370498 |
| 62 | IRAK1 | 0.99600706 |
| 63 | MUSK | 0.98317665 |
| 64 | TIE1 | 0.94136978 |
| 65 | MAP2K7 | 0.93903074 |
| 66 | PRKAA1 | 0.93399294 |
| 67 | PTK2B | 0.91803047 |
| 68 | PLK2 | 0.87564096 |
| 69 | RET | 0.85909703 |
| 70 | BMPR1B | 0.85852985 |
| 71 | EPHA3 | 0.84185348 |
| 72 | EPHA4 | 0.83430144 |
| 73 | FGFR3 | 0.82130921 |
| 74 | CAMKK2 | 0.82045037 |
| 75 | PRKCE | 0.80411435 |
| 76 | BCR | 0.80227705 |
| 77 | SGK2 | 0.80210436 |
| 78 | ATM | 0.78676891 |
| 79 | MTOR | 0.78626594 |
| 80 | PDGFRB | 0.77485040 |
| 81 | SIK1 | 0.76148504 |
| 82 | DYRK1B | 0.73530922 |
| 83 | MARK2 | 0.73415625 |
| 84 | PRKD2 | 0.72307229 |
| 85 | STK38 | 0.71862294 |
| 86 | WNK1 | 0.71485594 |
| 87 | MARK3 | 0.70249165 |
| 88 | GRK7 | 0.70097393 |
| 89 | CHEK1 | 0.69325450 |
| 90 | PDK2 | 0.68617673 |
| 91 | PKN2 | 0.67267702 |
| 92 | CAMK1D | 0.65900525 |
| 93 | CDC42BPA | 0.63414184 |
| 94 | FES | 0.61556609 |
| 95 | CHUK | 0.60291367 |
| 96 | ATR | 0.58697883 |
| 97 | CAMK1 | 0.58504910 |
| 98 | PRKCQ | 0.58161909 |
| 99 | DMPK | 0.57341220 |
| 100 | STK39 | 0.56215201 |
| 101 | PRKAA2 | 0.55915438 |
| 102 | KIT | 0.55862870 |
| 103 | STK3 | 0.55623048 |
| 104 | PBK | 0.54469004 |
| 105 | PIK3CG | 0.54207193 |
| 106 | STK24 | 0.54201938 |
| 107 | PAK2 | 0.53939594 |
| 108 | CDK6 | 0.53031859 |
| 109 | STK4 | 0.52079928 |
| 110 | BTK | 0.51708905 |
| 111 | LYN | 0.51618063 |
| 112 | HIPK2 | 0.49134340 |
| 113 | OXSR1 | 0.48981411 |
| 114 | TTN | 0.48618435 |
| 115 | CDK9 | 0.47813695 |
| 116 | RPS6KA4 | 0.47344809 |
| 117 | PRKG1 | 0.46591995 |
| 118 | ABL1 | 0.46467830 |
| 119 | MAP2K2 | 0.45973596 |
| 120 | CSNK1G1 | 0.45541998 |
| 121 | ACVR1B | 0.45274355 |
| 122 | IKBKE | 0.45131894 |
| 123 | CAMK2A | 0.44791210 |
| 124 | LATS1 | 0.44717948 |
| 125 | CDK8 | 0.44388948 |
| 126 | SGK1 | 0.44183388 |
| 127 | CSNK1A1L | 0.43980543 |
| 128 | NTRK2 | 0.43665801 |
| 129 | MELK | 0.43142023 |
| 130 | CSF1R | 0.42581097 |
| 131 | CDK1 | 0.42072378 |
| 132 | MAPK1 | 0.41550315 |
| 133 | SGK494 | 0.41237933 |
| 134 | SGK223 | 0.41237933 |
| 135 | FGR | 0.40880454 |
| 136 | MAPK10 | 0.40368757 |
| 137 | CDK2 | 0.40154485 |
| 138 | EIF2AK1 | 0.39911442 |
| 139 | JAK1 | 0.39861552 |
| 140 | CAMK4 | 0.38421902 |
| 141 | DYRK1A | 0.38289233 |
| 142 | IKBKB | 0.37790258 |
| 143 | CDK4 | 0.37653898 |
| 144 | RPS6KB1 | 0.37554464 |
| 145 | CLK1 | 0.37166805 |
| 146 | PNCK | 0.36371416 |
| 147 | EGFR | 0.36362523 |
| 148 | MAPK7 | 0.35289037 |
| 149 | WNK4 | 0.34678822 |
| 150 | CAMK2D | 0.32351659 |
| 151 | PAK3 | 0.32026042 |
| 152 | SGK3 | 0.31447633 |
| 153 | PTK2 | 0.30932949 |
| 154 | TNK2 | 0.29801598 |
| 155 | CAMK2B | 0.29381716 |
| 156 | PRKACA | 0.28848380 |
| 157 | LCK | 0.28533197 |
| 158 | STK38L | 0.28297714 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 3.16562478 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 2.97318282 |
| 3 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.25714651 |
| 4 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 2.22916912 |
| 5 | Phototransduction_Homo sapiens_hsa04744 | 2.07863706 |
| 6 | Taste transduction_Homo sapiens_hsa04742 | 2.05292060 |
| 7 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.01394354 |
| 8 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.95025983 |
| 9 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.93379133 |
| 10 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.88498760 |
| 11 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.83036809 |
| 12 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.79413620 |
| 13 | Colorectal cancer_Homo sapiens_hsa05210 | 1.79325288 |
| 14 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.77214373 |
| 15 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.76848473 |
| 16 | Endometrial cancer_Homo sapiens_hsa05213 | 1.72695104 |
| 17 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.71444976 |
| 18 | Morphine addiction_Homo sapiens_hsa05032 | 1.69940738 |
| 19 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.68599664 |
| 20 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.63625448 |
| 21 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.59697443 |
| 22 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.58779583 |
| 23 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.57105250 |
| 24 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.54832914 |
| 25 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.53044830 |
| 26 | Hepatitis B_Homo sapiens_hsa05161 | 1.46601770 |
| 27 | Insulin resistance_Homo sapiens_hsa04931 | 1.40353544 |
| 28 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.39058945 |
| 29 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.38975624 |
| 30 | Prostate cancer_Homo sapiens_hsa05215 | 1.37954755 |
| 31 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.37180568 |
| 32 | Adherens junction_Homo sapiens_hsa04520 | 1.36616467 |
| 33 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.35964882 |
| 34 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.35885398 |
| 35 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.34326815 |
| 36 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.30709978 |
| 37 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.30651570 |
| 38 | Retinol metabolism_Homo sapiens_hsa00830 | 1.29471555 |
| 39 | Other glycan degradation_Homo sapiens_hsa00511 | 1.29347483 |
| 40 | Alcoholism_Homo sapiens_hsa05034 | 1.27855120 |
| 41 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.27793106 |
| 42 | Platelet activation_Homo sapiens_hsa04611 | 1.27707566 |
| 43 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.26821528 |
| 44 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.26645396 |
| 45 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.26416805 |
| 46 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.26201552 |
| 47 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.26198838 |
| 48 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.24744045 |
| 49 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.24120715 |
| 50 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.24003276 |
| 51 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.22584056 |
| 52 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.19968490 |
| 53 | ABC transporters_Homo sapiens_hsa02010 | 1.19731905 |
| 54 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.15733520 |
| 55 | Thyroid cancer_Homo sapiens_hsa05216 | 1.14841240 |
| 56 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.13892678 |
| 57 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.13587030 |
| 58 | Insulin secretion_Homo sapiens_hsa04911 | 1.13072961 |
| 59 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.10939685 |
| 60 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.10223890 |
| 61 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.10131579 |
| 62 | Focal adhesion_Homo sapiens_hsa04510 | 1.09534924 |
| 63 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 1.09447759 |
| 64 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.09375806 |
| 65 | Salivary secretion_Homo sapiens_hsa04970 | 1.07316973 |
| 66 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.06196905 |
| 67 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.06088118 |
| 68 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.04734551 |
| 69 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.04268047 |
| 70 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.03927412 |
| 71 | GABAergic synapse_Homo sapiens_hsa04727 | 1.03374074 |
| 72 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.02253448 |
| 73 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.01929657 |
| 74 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.01392715 |
| 75 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.01366442 |
| 76 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.00943753 |
| 77 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.99918918 |
| 78 | Allograft rejection_Homo sapiens_hsa05330 | 0.99806165 |
| 79 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.99753500 |
| 80 | Circadian entrainment_Homo sapiens_hsa04713 | 0.98990806 |
| 81 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.97545070 |
| 82 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.97453709 |
| 83 | Base excision repair_Homo sapiens_hsa03410 | 0.97255823 |
| 84 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.96431255 |
| 85 | Glioma_Homo sapiens_hsa05214 | 0.94625815 |
| 86 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.92554740 |
| 87 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.92525450 |
| 88 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.90898573 |
| 89 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.90341350 |
| 90 | Cell cycle_Homo sapiens_hsa04110 | 0.88320782 |
| 91 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.87835678 |
| 92 | Axon guidance_Homo sapiens_hsa04360 | 0.87812708 |
| 93 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.84205991 |
| 94 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.83491925 |
| 95 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.82944976 |
| 96 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.81712897 |
| 97 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.81696429 |
| 98 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.81072959 |
| 99 | Lysine degradation_Homo sapiens_hsa00310 | 0.79449255 |
| 100 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.79018801 |
| 101 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.78778544 |
| 102 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.78656624 |
| 103 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.78194764 |
| 104 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.77820441 |
| 105 | Melanoma_Homo sapiens_hsa05218 | 0.77614374 |
| 106 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.76896480 |
| 107 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.76087608 |
| 108 | Shigellosis_Homo sapiens_hsa05131 | 0.76075870 |
| 109 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.75983841 |
| 110 | Cocaine addiction_Homo sapiens_hsa05030 | 0.75784056 |
| 111 | Hepatitis C_Homo sapiens_hsa05160 | 0.75746167 |
| 112 | Olfactory transduction_Homo sapiens_hsa04740 | 0.73826978 |
| 113 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.73594577 |
| 114 | Protein export_Homo sapiens_hsa03060 | 0.72684101 |
| 115 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.71188790 |
| 116 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.70251847 |
| 117 | Histidine metabolism_Homo sapiens_hsa00340 | 0.70246697 |
| 118 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.69845862 |
| 119 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.69393840 |
| 120 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.68251651 |
| 121 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.67547125 |
| 122 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.67486395 |
| 123 | Long-term depression_Homo sapiens_hsa04730 | 0.66346228 |
| 124 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.65092209 |
| 125 | Apoptosis_Homo sapiens_hsa04210 | 0.63983444 |
| 126 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.63424399 |
| 127 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.63258311 |
| 128 | Malaria_Homo sapiens_hsa05144 | 0.62973206 |
| 129 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.62178856 |
| 130 | Mineral absorption_Homo sapiens_hsa04978 | 0.62087559 |
| 131 | Asthma_Homo sapiens_hsa05310 | 0.61530138 |
| 132 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.61484533 |
| 133 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.60930306 |
| 134 | RNA transport_Homo sapiens_hsa03013 | 0.60749312 |
| 135 | Homologous recombination_Homo sapiens_hsa03440 | 0.60110622 |
| 136 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.60050797 |
| 137 | Measles_Homo sapiens_hsa05162 | 0.59815517 |
| 138 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.59675341 |
| 139 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.59665875 |
| 140 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.59640125 |
| 141 | Pathways in cancer_Homo sapiens_hsa05200 | 0.59561407 |
| 142 | RNA degradation_Homo sapiens_hsa03018 | 0.58839250 |
| 143 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.58469581 |
| 144 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.57582926 |
| 145 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.57506163 |
| 146 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.57096207 |
| 147 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.56939504 |
| 148 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.56472313 |
| 149 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.56258626 |
| 150 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.56235261 |
| 151 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.55614861 |
| 152 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.55066184 |
| 153 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.54996887 |
| 154 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.54462010 |
| 155 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.54232533 |
| 156 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.53586451 |
| 157 | Peroxisome_Homo sapiens_hsa04146 | 0.52893534 |
| 158 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.52395653 |
| 159 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.51531684 |
| 160 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.51483905 |
| 161 | Circadian rhythm_Homo sapiens_hsa04710 | 0.51340928 |
| 162 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.51295598 |
| 163 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.50868419 |
| 164 | Renin secretion_Homo sapiens_hsa04924 | 0.50469318 |
| 165 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.49512901 |
| 166 | Influenza A_Homo sapiens_hsa05164 | 0.49185404 |
| 167 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.48833211 |
| 168 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.48306320 |
| 169 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.47518767 |
| 170 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.47452056 |
| 171 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.47310431 |
| 172 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.46089980 |
| 173 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.46028242 |
| 174 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.45274592 |
| 175 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.44619049 |
| 176 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.43976037 |
| 177 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.42058590 |
| 178 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.41758263 |
| 179 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.38716561 |

